Opportunistic Infections Citation List: March 30 - April 12, 2012

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

1. Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis. Debnath, J., S. Siricilla, B. Wan, D.C. Crick, A.J. Lenaerts, S.G. Franzblau, and M. Kurosu. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22449052].

[PubMed]. OI_0330-041212.

2. Antioxidant, Antitubercular and Cytotoxic Activities of Piper Imperiale. Diaz, L.E., D.R. Munoz, R.E. Prieto, S.A. Cuervo, D.L. Gonzalez, J.D. Guzman, and S. Bhakta. Molecules (Basel, Switzerland), 2012. 17(4): p. 4142-4157; PMID[22481537].

[PubMed]. OI_0330-041212.

3. Structure-based Design of Novel Benzoxazinorifamycins with Potent Binding Affinity to Wild-type and Rifampin-resistant Mutant Mycobacterium tuberculosis RNA Polymerases. Gill, S.K., H. Xu, P.D. Kirchhoff, T. Cierpicki, A.J. Turbiak, B. Wan, N. Zhang, K.W. Peng, S.G. Franzblau, G.A. Garcia, and H.D. Showalter. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22452568]. [PubMed]. OI_0330-041212.

4. Antimicrobial Antioxidant Daucane Sesquiterpenes from Ferula hermonis Boiss. Ibraheim, Z.Z., W.M. Abdel-Mageed, H. Dai, H. Guo, L. Zhang, and M. Jaspars. Phytotherapy Research : PTR, 2012. 26(4): p. 579-586; PMID[21953875].

[PubMed]. OI_0330-041212.

5. Inhibition of 1-Deoxy-D-xylulose-5-phosphate reductoisomerase (dxr): A Review of the Synthesis and Biological Evaluation of Recent Inhibitors. Jackson, E.R. and C.S. Dowd. Current Topics in Medicinal Chemistry, 2012. 12(7): p. 706-728; PMID[22283814].

[PubMed]. OI_0330-041212.

6. Design, Synthesis and in Vivo/in Vitro Screening of Novel Chlorokojic Acid Derivatives. Karakaya, G., M.D. Aytemir, B. Ozcelik, and U. Calis. Journal of Enzyme Inhibition and Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22468745].

[PubMed]. OI_0330-041212.

7. Synthesis and in Vitro Anti-tubercular Evaluation of 1,2,3-Triazole Tethered beta-Lactam-Ferrocene and beta-Lactam-Ferrocenylchalcone Chimeric Scaffolds. Kumar, K., P. Singh, L. Kremer, Y. Guerardel, C. Biot, and V. Kumar. Dalton Transactions (Cambridge, England : 2003), 2012. [Epub ahead of print]; PMID[22473422].

[PubMed]. OI_0330-041212.

8. Derivatives of 3-Isoxazolecarboxylic acid Esters - a Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis. Lilienkampf, A., M. Pieroni, S.G. Franzblau, W.R. Bishai, and A.P. Kozikowski. Current Topics in Medicinal Chemistry, 2012. 12(7): p. 729-734; PMID[22283815].

[PubMed]. OI_0330-041212.

9. Synthesis and Evaluation of Novel Monosubstituted Sulfonylurea Derivatives as Antituberculosis Agents. Pan, L., Y. Jiang, Z. Liu, X.H. Liu, G. Wang, Z.M. Li, and D. Wang. European Journal of Medicinal Chemistry, 2012. 50: p. 18-26; PMID[22326144].

[PubMed]. OI_0330-041212.

10. Combining Cheminformatics Methods and Pathway Analysis to Identify Molecules with Whole-cell Activity against Mycobacterium tuberculosis. Sarker, M., C. Talcott, P. Madrid, S. Chopra, B.A. Bunin, G. Lamichhane, J.S. Freundlich, and S. Ekins. Pharmaceutical Research, 2012. [Epub ahead of print]; PMID[22477069].

[PubMed]. OI_0330-041212.

11. Drug Design and Identification of Potent Leads against Mycobacterium tuberculosis Thymidine Monophosphate Kinase. Van Calenbergh, S., S. Pochet, and H. Munier-Lehmann. Current Topics in Medicinal Chemistry, 2012. 12(7): p. 694-705; PMID[22283813].

[PubMed]. OI_0330-041212.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

12. In Vitro and in Vivo Antimalarial Activities of T-2307, a Novel Arylamidine. Kimura, A., H. Nishikawa, N. Nomura, J. Mitsuyama, S. Fukumoto, N. Inoue, and S. Kawazu. Antimicrobial Agents and Chemotherapy, 2012. 56(4): p. 2191-2193; PMID[22252809].

[PubMed]. OI_0330-041212.

13. Synthesis and Evaluation of Peptidyl Alpha,Beta-unsaturated Carbonyl Derivatives as Anti-malarial Calpain Inhibitors. Mallik, S.K., Y. Li da, M. Cui, H.O. Song, H. Park, and H.S. Kim. Archives of Pharmacal Research, 2012. 35(3): p. 469-479; PMID[22477194].

[PubMed]. OI_0330-041212.

14. In Vitro Activity of Extracts and Isolated Polyphenols from West African Medicinal Plants against Plasmodium falciparum. Ndjonka, D., B. Bergmann, C. Agyare, F.M. Zimbres, K. Luersen, A. Hensel, C. Wrenger, and E. Liebau. Parasitology Research, 2012. [Epub ahead of print]; PMID[22476602].

[PubMed]. OI_0330-041212.

ANTILEISHMANIAL COMPOUNDS (Leishmania spp.)

15. Antileishmanial, Antitrypanosomal, and Cytotoxic Screening of Ethnopharmacologically Selected Peruvian Plants. Gonzalez-Coloma, A., M. Reina, C. Saenz, R. Lacret, L. Ruiz-Mesia, V.J. Aran, J. Sanz, and R.A. Martinez-Diaz. Parasitology Research, 2012. 110(4): p. 1381-1392; PMID[21922239].

[PubMed]. OI_0330-041212.

16. Synthesis and Anti-Leishmanial Activity of 5-(5-Nitrofuran-2-Yl)-1,3,4-Thiadiazol-2-Amines Containing N-[(1-Benzyl-1h-1,2,3-Triazol-4-Yl)Methyl] Moieties. Tahghighi, A., S. Razmi, M. Mahdavi, P. Foroumadi, S.K. Ardestani, S. Emami, F. Kobarfard, S. Dastmalchi, A. Shafiee, and A. Foroumadi. European Journal of Medicinal Chemistry, 2012. 50: p. 124-128; PMID[22336386].

[PubMed]. OI_0330-041212.

Citations from the ISI Web of Knowledge Listings for O.I.

17. Antimycobacterial Activity of Ferutinin Alone and in Combination with Antitubercular Drugs against a Rapidly Growing Surrogate of Mycobacterium tuberculosis. Abourashed, E.A., A.M. Galal, and A.M. Shibl. Natural Product Research, 2011. 25(12): p. 1142-1149; ISI[000299687700003].

[WOS]. OI_0330-041212.

18. Efficient One-pot Preparation of Novel Fused Chromeno 2,3-D pyrimidine and Pyrano 2,3-D pyrimidine Derivatives. Aly, H.M. and M.M. Kamal. European Journal of Medicinal Chemistry, 2012. 47: p. 18-23; ISI[000301169800002].

[WOS]. OI_0330-041212.

19. The Additive and Synergistic Antimicrobial Effects of Select Frankincense and Myrrh Oils - a Combination from the Pharaonic Pharmacopoeia. De Rapper, S., S.F. Van Vuuren, G.P.P. Kamatou, A.M. Viljoen, and E. Dagne. Letters in Applied Microbiology, 2012. 54(4): p. 352-358; ISI[000301286000013].

[WOS]. OI_0330-041212.

20. In Vitro Evaluation of Antimicrobial and Antioxidant Activities of Some Tunisian Vegetables. Edziri, H., S. Ammar, L. Souad, M.A. Mahjoub, M. Mastouri, M. Aouni, Z. Mighri, and L. Verschaeve. South African Journal of Botany, 2012. 78: p. 252-256; ISI[000301016800032].

[WOS]. OI_0330-041212.

21. Antimicrobial Potential of Gemmo-modified Extracts of Terminalia arjuna and Euphorbia tirucalli. Jahan, N., R. Khalil Ur, S. Ali, and I.A. Bhatti. International Journal of Agriculture and Biology, 2011. 13(6): p. 1001-1005; ISI[000297573000027].

[WOS]. OI_0330-041212.

22. Isonicotinic acid hydrazide Derivatives: Synthesis, Antimycobacterial, Antiviral, Antimicrobial Activity and QSAR Studies. Judge, V., B. Narasimhan, M. Ahuja, D. Sriram, and P. Yogeeswari. Letters in Drug Design & Discovery, 2011. 8(9): p. 792-810; ISI[000301480100002].

[WOS]. OI_0330-041212.

23. Synthesis, Spectral Characterization, in-Vitro Antibacterial and Antifungal Activities of Novel (2E)-Ethyl-2-(2-(2, 4-dinitrophenyl) hydrazono)-4-(naphthalen-2-yl)-6-arylcyclohex-3-enecarboxylates. Kanagarajan, V., J. Thanusu, and M. Gopalakrishnan. Iranian Journal of Pharmaceutical Research, 2011. 10(4): p. 711-725; ISI[000299297400006].

[WOS]. OI_0330-041212.

24. Generation and Exploration of New Classes of Antitubercular Agents: The Optimization of Oxazolines, Oxazoles, Thiazolines, Thiazoles to Imidazo 1,2-a Pyridines and Isomeric 5,6-Fused Scaffolds. Moraski, G.C., L.D. Markley, M. Chang, S. Cho, S.G. Franzblau, C.H. Hwang, H. Boshoff, and M.J. Miller. Bioorganic & Medicinal Chemistry, 2012. 20(7): p. 2214-2220; ISI[000301379300003].

[WOS]. OI_0330-041212.

25. Synthesis and Antimycobacterial Activity of Various 1-(8-Quinolinyloxy)-3-piperazinyl(piperidinyl)-5-(4-cyano-3-trifluoromet hylphenylamino)-S-triazines. Patel, R.V., P. Kumari, D.P. Rajani, and K.H. Chikhalia. Acta Chimica Slovenica, 2011. 58(4): p. 802-810; ISI[000298811900023].

[WOS]. OI_0330-041212.

26. Synthesis, Characterization, DNA Cleavage, and in-Vitro Antimicrobial Studies of Co(II), Ni(II), and Cu(II) Complexes with Schiff Bases of Coumarin Derivatives. Patil, S.A., V.H. Naik, A.D. Kulkarni, S.N. Unki, and P.S. Badami. Journal of Coordination Chemistry, 2011. 64(15): p. 2688-2697; ISI[000299465800011].

[WOS]. OI_0330-041212.

27. Camphorsulfonic acid Catalysed Facile Tandem Double Friedlander Annulation Protocol for the Synthesis of Phenoxy Linked Bisquinoline Derivatives and Discovery of Antitubercular Agents. Paul, N., M. Murugavel, S. Muthusubramanian, and D. Sriram. Bioorganic & Medicinal Chemistry Letters, 2012. 22(4): p. 1643-1648; ISI[000300404900032].

[WOS]. OI_0330-041212.

28. Evaluation of Antifungal Activity in Essential Oil of the Syzygium aromaticum (L.) by Extraction, Purification and Analysis of Its Main Component Eugenol. Rana, I.S., A.S. Rana, and R.C. Rajak. Brazilian Journal of Microbiology, 2011. 42(4): p. 1269-1277; ISI[000300430600004].

[WOS]. OI_0330-041212.

29. Cytotoxic and Antifungal Activities of 5-Hydroxyramulosin, a Compound Produced by an Endophytic Fungus Isolated from Cinnamomum mollisimum. Santiago, C., C. Fitchett, M.H.G. Munro, J. Jalil, and J. Santhanam. Evidence-Based Complementary and Alternative Medicine, 2012. [Epub ahead of print]; ISI[000301370700001].

[WOS]. OI_0330-041212.

30. Metal-based Biologically Active Compounds: Synthesis, Spectral, and Antimicrobial Studies of Cobalt, Nickel, Copper, and Zinc Complexes of Triazole-derived Schiff Bases. Singh, K., Y. Kumar, P. Puri, C. Sharma, and K.R. Aneja. Bioinorganic Chemistry and Applications, 2011. [Epub ahead of print]; ISI[000298692700001].

[WOS]. OI_0330-041212.

31. Isoniazid Metal Complex Reactivity and Insights for a Novel Anti-tuberculosis Drug Design. Sousa, E.H.S., L.A. Basso, D.S. Santos, I.C.N. Diogenes, E. Longhinotti, L.G.D. Lopes, and I.D. Moreira. Journal of Biological Inorganic Chemistry, 2012. 17(2): p. 275-283; ISI[000301185800010].

[WOS]. OI_0330-041212.

32. The Mechanism of Antifungal Action of Essential Oil from Dill (Anethum graveolens L.) on Aspergillus flavus. Tian, J., X.Q. Ban, H. Zeng, J.S. He, Y.X. Chen, and Y.W. Wang. Plos One, 2012. 7(1); ISI[000301454400067].

[WOS]. OI_0330-041212.

33. Phytochemical Screening and Antimicrobial Activity of Roots of Murraya koenigii (Linn.) Spreng. (Rutaceae). Vats, M., H. Singh, and S. Sardana. Brazilian Journal of Microbiology, 2011. 42(4): p. 1569-1573; ISI[000300430600044].

[WOS]. OI_0330-041212.

34. Synthesis, Antimicrobial, Antimycobacterial and Structure-Activity Relationship of Substituted Pyrazolo-, Isoxazolo-, Pyrimido- and Mercaptopyrimidocyclohepta B Indoles. Yamuna, E., R.A. Kumar, M. Zeller, and K.J.R. Prasad. European Journal of Medicinal Chemistry, 2012. 47: p. 228-238; ISI[000301169800026].

[WOS]. OI_0330-041212.